VolitionRX Ltd
VolitionRX Ltd (VNRX) Covered Calls
As of September 21, 2026, VNRX has 1 covered call opportunities in the coming three months. Return ranges from 880.8 to 880.8% until expiration. Annualized return ranges from 1,553.0 to 1,553.0%. The nearest expiration is April 16, 2027. Maximum potential profit is $229.
Read more
Running VNRX covered calls helps you generate consistent income from VolitionRX Ltd's shares you already own, turning a long stock position into a yield-producing asset. A covered call on VolitionRX Ltd involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best VNRX covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if VNRX stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling VNRX covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given VolitionRX Ltd covered call is worth writing.
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.
Income-focused investors, long-term VNRX holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling VNRX covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best VolitionRX Ltd covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryMedical Devices
- SectorHealthcare
- IV percentile—
- Market cap (M$)5
- 52 weeks high-98.24%
- 52 weeks low8.33%
- Analyst recommendationBuy
1.67 - Target price$8.04
2992.31% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-12
- P/E—
- Future P/E—
- EPS (ttm)-3.84
- EPS growth next 5 years57.20%
As of September 21, 2026
| 2027-04-16 | 207 | 2.50 | 861.54 | 0.05 | 0.10 | 229.00 | 880.77 | 1553.05 | -19.23 | +0.45 | 113 | 0.05 |
As of September 21, 2026
Sell covered calls with the data behind you
Find the best VNRX covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→